Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Tango Therapeutics, Inc.
Tango Therapeutics, Inc.
St. Jude Children's Research Hospital
STORM Therapeutics LTD
Novartis
National Institutes of Health Clinical Center (CC)
Polaris Group
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Kivu Bioscience Inc.
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Instituto do Cancer do Estado de São Paulo
EMD Serono
Institut Claudius Regaud
Memorial Sloan Kettering Cancer Center
Thomas Jefferson University
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Stanford University
National Cancer Institute (NCI)
Fred Hutchinson Cancer Center
Duke University
Second Affiliated Hospital, School of Medicine, Zhejiang University
Bayer
Second Affiliated Hospital, School of Medicine, Zhejiang University
University Hospital Heidelberg
Washington University School of Medicine
Asociación Europea y Latinoamericana SELNET para la Investigación en Sarcomas
Turning Point Therapeutics, Inc.
Eastern Cooperative Oncology Group
Memorial Sloan Kettering Cancer Center
Medical University of South Carolina
Second Affiliated Hospital, School of Medicine, Zhejiang University
Case Comprehensive Cancer Center
National Institutes of Health Clinical Center (CC)
Italian Sarcoma Group
Inhibrx Biosciences, Inc
Centre Oscar Lambret
Roswell Park Cancer Institute
Ratio Therapeutics, Inc.
Universitaire Ziekenhuizen KU Leuven
University Health Network, Toronto
National Institutes of Health Clinical Center (CC)
QBiotics Group Limited
University of Florida
Jonsson Comprehensive Cancer Center
University Hospital Heidelberg
City of Hope Medical Center
Wake Forest University Health Sciences